RET GENE MUTATIONS, EDTA BLOOD

This test detects mutations in the RET gene, which is associated with certain cancers, including medullary thyroid cancer. It helps guide genetic counseling and cancer risk management.

Also known asRet Gene Mutations Ret Gene Mutations

Available via

Home Collection, Lab Visit

Contains

1 parameters

Earliest reports in

7 Working Days

Test details

RET GENE MUTATIONS, EDTA BLOOD Test in Mangaluru Overview

Preparations

No special preparations needed

Test included
RET GENE MUTATIONS, EDTA BLOOD includes 1 parameter

  • Ret Gene Mutations
Frequently Asked Questions

The RET Gene Mutations test detects mutations in the RET proto-oncogene, which are associated with multiple endocrine neoplasia type 2 (MEN2) and medullary thyroid carcinoma (MTC).

Individuals with a family history of MEN2, MTC, or those with thyroid nodules suggestive of malignancy should take this test.

A blood sample is collected for DNA analysis to identify mutations in the RET gene.

Positive results indicate a genetic predisposition to MEN2 and MTC, necessitating proactive medical management.

Positive cases may require preventive thyroidectomy, regular surveillance, and genetic counseling for family members.

Test code

RD1441

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Edta Whole BloodLavender Vacutainer5 ML

Specimen stability information

Edta Whole Blood

Specimen rejection criteria

Test run frequency

Every Day TIME - 10:30

Turn around time

7 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

RET GENE MUTATIONS, EDTA BLOOD

6500